• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有或不伴有内界膜剥除的玻璃体切除术治疗糖尿病性黄斑水肿

Vitrectomy for diabetic macular edema with and without internal limiting membrane removal.

作者信息

Yamamoto Teiko, Hitani Koichiro, Sato Yukihiro, Yamashita Hidetoshi, Takeuchi Shinobu

机构信息

Department of Ocular Cellular Engineering, Yamagata University Hospital, Yamagata, Japan.

出版信息

Ophthalmologica. 2005 Jul-Aug;219(4):206-13. doi: 10.1159/000085729.

DOI:10.1159/000085729
PMID:16088239
Abstract

PURPOSE

To compare the efficacy of surgically removing or not removing the internal limiting membrane (ILM) during pars plana vitrectomy on the visual acuity and retinal thickness in eyes with diabetic macular edema.

METHODS

A prospective, case-control study was carried out on 30 eyes of 29 patients undergoing pars plana vitrectomy for diabetic macular edema. Fifteen eyes underwent pars plana vitrectomy with ILM removal and 15 eyes without ILM removal.

RESULTS

In 7 of 15 eyes (47%) in the ILM-removed group, the visual acuity improved by 0.2 or more log of the minimum angle of resolution (log MAR) units and remained unchanged in 8 eyes (53%). In the ILM-preserved group, the final visual acuity improved in 9 of 15 eyes (60%) and remained unchanged in 6 eyes (40%). The difference in visual acuity between the two groups after 11 months the surgery was not significant (Fisher's exact test, p=0.4938). In the ILM-removed group, the final retinal thickness decreased by more than 20% of the preoperative retinal thickness in 12 of 15 eyes (80%), remained unchanged in 2 of 15 eyes (13%), and increased in 1 of 15 eyes (7%). In the ILM-preserved group, the final retinal thickness decreased in 13 of 15 eyes (87%) and remained unchanged in 2 of 15 eyes (23%). The differences in the changes in the retinal thickness between the two groups were not statistically significant (Fisher's exact test, p=0.5945).

CONCLUSION

Vitrectomy in eyes with diabetic macular edema without ILM removal was as effective in reducing the retinal thickness and improving the visual acuity as eyes with ILM removal. We conclude that ILM need not be removed to treat eyes with diabetic macular edema.

摘要

目的

比较在糖尿病性黄斑水肿患者的玻璃体切除术中,切除或不切除内界膜(ILM)对视力和视网膜厚度的影响。

方法

对29例接受玻璃体切除术治疗糖尿病性黄斑水肿的患者的30只眼进行了一项前瞻性病例对照研究。15只眼在玻璃体切除术中切除了ILM,15只眼未切除ILM。

结果

在切除ILM组的15只眼中,有7只眼(47%)视力提高了0.2或更多最小分辨角对数(log MAR)单位,8只眼(53%)视力保持不变。在保留ILM组中,15只眼中有9只眼(60%)最终视力提高,6只眼(40%)视力保持不变。术后11个月两组间视力差异无统计学意义(Fisher精确检验,p = 0.4938)。在切除ILM组中,15只眼中有12只眼(80%)最终视网膜厚度较术前减少超过20%,15只眼中有2只眼(13%)保持不变,15只眼中有1只眼(7%)增加。在保留ILM组中,15只眼中有13只眼(87%)最终视网膜厚度减少,15只眼中有2只眼(23%)保持不变。两组间视网膜厚度变化的差异无统计学意义(Fisher精确检验,p = 0.5945)。

结论

在糖尿病性黄斑水肿患者中,不切除ILM的玻璃体切除术在降低视网膜厚度和提高视力方面与切除ILM的手术效果相同。我们得出结论,治疗糖尿病性黄斑水肿无需切除ILM。

相似文献

1
Vitrectomy for diabetic macular edema with and without internal limiting membrane removal.伴有或不伴有内界膜剥除的玻璃体切除术治疗糖尿病性黄斑水肿
Ophthalmologica. 2005 Jul-Aug;219(4):206-13. doi: 10.1159/000085729.
2
Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.改良格栅激光光凝术与玻璃体切割联合内界膜剥除术治疗糖尿病性黄斑水肿的比较
Am J Ophthalmol. 2005 May;139(5):795-801. doi: 10.1016/j.ajo.2004.12.017.
3
Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.糖尿病性黄斑水肿行玻璃体后皮质切除术联合内界膜剥除术的长期预后
Retina. 2007 Jun;27(5):557-66. doi: 10.1097/01.iae.0000249390.61854.d5.
4
[Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].糖尿病性黄斑水肿眼行玻璃体切除术联合视网膜内界膜(ILM)剥除术
Klin Oczna. 2006;108(7-9):273-7.
5
Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema.玻璃体切割联合内界膜剥除术治疗持续性糖尿病性黄斑水肿
Am J Ophthalmol. 2005 Mar;139(3):447-54. doi: 10.1016/j.ajo.2004.09.076.
6
Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.手术切除后玻璃体膜和内界膜后糖尿病性黄斑水肿的消退
Retina. 2000;20(2):126-33.
7
Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.玻璃体后皮质切除术联合内界膜剥除术治疗糖尿病性黄斑水肿
Retina. 2008 Mar;28(3):410-9. doi: 10.1097/IAE.0b013e31816102f2.
8
Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy.经扁平部玻璃体切割术治疗后,糖尿病性黄斑水肿患者眼睛的视力得到改善。
Ophthalmologica. 2004 Nov-Dec;218(6):378-84. doi: 10.1159/000080940.
9
Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema.玻璃体切除术与染料增强内界膜剥除联合格栅激光治疗弥漫性糖尿病性黄斑水肿的比较评估
Graefes Arch Clin Exp Ophthalmol. 2007 Mar;245(3):360-8. doi: 10.1007/s00417-006-0456-6. Epub 2006 Nov 9.
10
[Clinical observation of vitrectomy for treatment of diffuse nontraditional diabetic macular edema].玻璃体切除术治疗弥漫性非典型糖尿病性黄斑水肿的临床观察
Zhonghua Yan Ke Za Zhi. 2011 Jun;47(6):492-6.

引用本文的文献

1
Surgical Management of Diabetic Macular Edema.糖尿病性黄斑水肿的手术治疗。
Curr Diab Rep. 2023 Jun;23(6):119-125. doi: 10.1007/s11892-023-01505-3. Epub 2023 Apr 12.
2
Review of clinical studies and recommendation for a therapeutic flow chart for diabetic macular edema.糖尿病性黄斑水肿的临床研究综述及治疗流程图推荐。
Graefes Arch Clin Exp Ophthalmol. 2021 Apr;259(4):815-836. doi: 10.1007/s00417-020-04936-w. Epub 2020 Sep 30.
3
Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy.
雷珠单抗预处理在重度增殖性糖尿病视网膜病变伴糖尿病性黄斑水肿的玻璃体切割联合内界膜剥除术中的应用
Diabetes Ther. 2020 Jun;11(6):1397-1406. doi: 10.1007/s13300-020-00822-0. Epub 2020 Apr 30.
4
The Evolving Treatment of Diabetic Retinopathy.糖尿病视网膜病变的治疗进展
Clin Ophthalmol. 2020 Mar 4;14:653-678. doi: 10.2147/OPTH.S236637. eCollection 2020.
5
Revisiting pars plana vitrectomy in the primary treatment of diabetic macular edema in the era of pharmacological treatment.在药物治疗时代重新审视玻璃体切割术在糖尿病性黄斑水肿初始治疗中的应用
Taiwan J Ophthalmol. 2019 Dec 13;9(4):224-232. doi: 10.4103/tjo.tjo_61_19. eCollection 2019 Oct-Dec.
6
Internal Limiting Membrane Peeling for Persistent Submacular Fluid after Successful Repair of Diabetic Tractional Retinal Detachment.糖尿病性牵拉性视网膜脱离成功修复后持续性黄斑下液的内界膜剥除术
J Ophthalmol. 2019 Oct 23;2019:8074960. doi: 10.1155/2019/8074960. eCollection 2019.
7
Efficacy and safety of vitrectomy with internal limiting membrane peeling for diabetic macular edema: a Meta-analysis.玻璃体切除术联合内界膜剥除治疗糖尿病性黄斑水肿的疗效与安全性:一项Meta分析
Int J Ophthalmol. 2018 Nov 18;11(11):1848-1855. doi: 10.18240/ijo.2018.11.18. eCollection 2018.
8
Outcomes of vitrectomy, membranectomy and internal limiting membrane peeling in patients with refractory diabetic macular edema and non-tractional epiretinal membrane.玻璃体切除术、膜切除术及内界膜剥除术治疗难治性糖尿病性黄斑水肿合并非牵引性视网膜前膜的疗效
J Curr Ophthalmol. 2016 Aug 27;28(4):199-205. doi: 10.1016/j.joco.2016.08.006. eCollection 2016 Dec.
9
Complications of Macular Peeling.黄斑剥脱的并发症
J Ophthalmol. 2015;2015:467814. doi: 10.1155/2015/467814. Epub 2015 Sep 3.
10
Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema. A prospective, randomized comparative study.玻璃体视网膜切除术与三次玻璃体内注射贝伐单抗治疗非牵引性糖尿病黄斑水肿的前瞻性随机对照研究。
Indian J Ophthalmol. 2015 Jun;63(6):504-10. doi: 10.4103/0301-4738.162602.